Press Releases :: Cellectar Biosciences, Inc. (CLRB)

Year

Release Type

Jul 9, 2019

Cellectar Receives FDA Fast Track Designation for CLR 131 in Diffuse Large B-Cell Lymphoma

May 21, 2019

Cellectar Expands Third Cohort of its Phase 2 CLOVER-1 Study of CLR 131

May 20, 2019

Cellectar Biosciences Announces Closing of $10.0 Million Financing

May 16, 2019

Cellectar Biosciences Announces $10.0 Million Financing